Will Amyris stock price grow / rise / go up? Yes. The AMRS stock price can go up from 4.080 USD to 5.307 USD in one year.
Is AMRS overvalued?
High growth potential and slightly overvalued.
Is Amyris good?
Zacks' proprietary data indicates that Amyris, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the AMRS shares relative to the market in the next few months. The financial health and growth prospects of AMRS, demonstrate its potential to underperform the market.
What kind of company is AMRS?
Type Public
------------ -----------------------------------------------------------------------
Traded as Nasdaq: AMRS Russell 2000 Index component
Industry Renewable fuels, antimalarials, renewable chemicals, renewable products
Founded 2003
Headquarters Emeryville, California, USA
Is AMRS stock a good buy?
Out of 5 analysts, 3 (60%) are recommending AMRS as a Strong Buy, 2 (40%) are recommending AMRS as a Buy, 0 (0%) are recommending AMRS as a Hold, 0 (0%) are recommending AMRS as a Sell, and 0 (0%) are recommending AMRS as a Strong Sell. What is AMRS's earnings growth forecast for 2022-2024?
Who owns Amyris Inc?
Type Public
------------ ------------------------------------------------------------------------------------------------------
Founded 2003
Headquarters Emeryville, California, USA
Key people John G. Melo (CEO) Eduardo Alvarez (COO) Han Kieftenbeld (CFO) Nicole Kelsey (Gen.Counsel & Secretary)
Brands Biossance, Pipette, Purecane, Costa Brazil, EcoFabulous, Rose Inc, Terasana, JVN and OLIKA.
Who owns the most stock in Viacom?
Stockholder Stake Shares owned
-------------------------------- ------ ------------
The Vanguard Group, Inc. 10.29% 62,416,683
SSgA Funds Management, Inc. 5.38% 32,612,933
BlackRock Fund Advisors 5.03% 30,488,428
Susquehanna Financial Group LLLP 3.11% 18,885,651
Who bought IDEX stock?
Stockholder Stake Shares bought / sold
------------------------------------ ------ --------------------
The Vanguard Group, Inc. 11.00% +57,725
T. Rowe Price Associates, Inc. (I 5.32% -325,534
BlackRock Fund Advisors 4.64% +53,032
Impax Asset Management Ltd. 4.26% +266,327
What company owns Pipette?
Amyris Inc.
When was amyris founded?
2003
What company owns Biossance?
Amyris
Is Amyris stock a good buy?
Is Amyris a buy right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amyris in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Amyris stock.
What products does amyris make?
Amyris is proud to own three consumer brands - all built around its No Compromise® promise of clean ingredients: Biossance™ clean beauty skincare, Pipette™ clean baby skincare and Purecane™, a zero-calorie sweetener naturally derived from sugarcane.
What kind of company is Amyris?
Type Public
------------ -----------------------------------------------------------------------
Industry Renewable fuels, antimalarials, renewable chemicals, renewable products
Founded 2003
Headquarters Emeryville, California, USA